Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001085146-25-004280·SAGE RHINO CAPITAL LLC
Schedule 13G ownership disclosure
VINCERX PHARMA INC
Common Stock · CUSIP: 92731L106
Event date: 2025-01-29
- Filing-level shares
- 4,260
- Percent of class
- 0%
- Sage Rhino Capital, LLC
Shares: 4,260 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-004280
- Form type
- SCHEDULE 13G/A
- Filer
- SAGE RHINO CAPITAL LLC
- CIK
- CIK 1771605
- Filed
- Jul 29, 2025
- Reporting period
- Jan 29, 2025
- Description
- Schedule 13G beneficial ownership